News in brief: Lung Foundation launches research fund; Single-inhaler triple therapy in real-world COPD study; ctDNA finds more targetable NSCLC mutations than biopsy

Research will continue to give hope in lung disease Lung Foundation Australia has launched its Hope Research Fund with a goal to raise $50 million by 2030 for research into lung cancer and other lung disease. CEO Mark Brooke said government research investment was lagging behind the total burden of lung disease meaning other sources ...

Already a member?

Login to keep reading.

© 2021 the limbic